Executive Summary

Oct 2019
PROSPECTS
High smoking prevalence presents challenges and opportunities to the category

Recent studies conducted by the European Commission and Eurobarometer on smokers’ attitudes towards tobacco products reveal that Bulgaria is the European country with the lowest numbers of ex-smokers per capita. In addition, the country has the highest average age of smokers who quit tobacco products.

Social acceptance of smoking remains a barrier to the uptake of NRT

Unlike most European countries, smoking is still widely socially acceptable in Bulgaria and this tends to make it difficult for the leading players in NRT smoking cessation aids to position their products as appealing to younger consumers. One major reason for high uptake of smoking among younger adults is that smoking prevalence remains high among female consumers, especially by European standards, while the lack of any taboo about smoking in front of children means that many Bulgarians grow up with the impression that smoking is perfectly acceptable at any age.

Reduced harm tobacco products present competition to NRT smoking cessation aids

The second half of the review period saw reduced harm tobacco products introduced to Bulgarian consumers. Notably, Philip Morris has introduced its breakthrough range of smoke-free alternatives into the country under the IQOS brand.

COMPETITIVE LANDSCAPE
Johnson & Johnson’s Nicorette remains virtually ubiquitous in NRT in Bulgaria

Nicorette by Johnson & Johnson remains the dominant brand in NRT smoking cessation aids, accounting for the vast majority category sales and dominating retail shelves in chemists/pharmacies throughout the country. Indeed, the brand success is based in no small part on the distribution partnerships that it has been able to establish and maintain with all of the country’s leading chained chemists/pharmacies.

Tabex challenges Nicorette by offering a more natural alternative

The local dietary supplements brand Tabex by Sopharma AD continues to present challenges to the category’s leading brand, Nicorette by Johnson & Johnson. Tabex is presented as a direct competitor to Nicorette and its appeal is based on its low price, the very favourable reputation of parent company Sopharma in Bulgaria and the fact that it is a herbal/traditional remedy is a major advantage in a country where herbal/traditional medicines are often valued over regular OTC options.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

NRT Smoking Cessation Aids in Bulgaria

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the NRT Smoking Cessation Aids industry in Bulgaria with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the NRT Smoking Cessation Aids industry in Bulgaria, our research will save you time and money while empowering you to make informed, profitable decisions.

The NRT Smoking Cessation Aids in Bulgaria market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Production, imports by origin, exports by destination
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of NRT Smoking Cessation Aids in Bulgaria?
  • What are the major brands in Bulgaria?
  • How have tobacco bans affected the sales of NRT Smoking Cessation Aids?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

NRT Smoking Cessation Aids in Bulgaria - Category analysis

HEADLINES

PROSPECTS

High smoking prevalence presents challenges and opportunities to the category
Social acceptance of smoking remains a barrier to the uptake of NRT
Reduced harm tobacco products present competition to NRT smoking cessation aids

COMPETITIVE LANDSCAPE

Johnson & Johnson’s Nicorette remains virtually ubiquitous in NRT in Bulgaria
Tabex challenges Nicorette by offering a more natural alternative

CATEGORY DATA

Table 1 Sales of NRT Smoking Cessation Aids by Category: Value 2014-2019
Table 2 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2015-2019
Table 4 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2016-2019
Table 5 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
Table 6 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024

Consumer Health in Bulgaria - Industry Overview

EXECUTIVE SUMMARY

Consumer health continues to benefit from economic develop and rising incomes
Limited spending power continues to suppress sales growth
The industry remains highly consolidated, with tight regulation stifling competition
Growth is recorded in internet retailing as online shopping begins to take off
Moderate sales growth expected in consumer health over the forecast period

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Distribution of Consumer Health by Format: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format and Category: % Value 2019
Table 15 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DEFINITIONS

SOURCES

Summary 1 Research Sources